HEADER TRANSFERASE 12-MAR-18 6FYI TITLE X-RAY STRUCTURE OF CLK2-KD(130-496)/TG003 AT 2.6A COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CDC-LIKE KINASE 2; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SPLICING, PHOSPHOTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 5 17-JAN-24 6FYI 1 REMARK REVDAT 4 03-OCT-18 6FYI 1 REMARK REVDAT 3 26-SEP-18 6FYI 1 JRNL REVDAT 2 12-SEP-18 6FYI 1 JRNL REVDAT 1 18-JUL-18 6FYI 0 JRNL AUTH J.KALLEN,C.BERGSDORF,B.ARNAUD,M.BERNHARD,M.BRICHET, JRNL AUTH 2 A.COBOS-CORREA,A.ELHAJOUJI,F.FREULER,I.GALIMBERTI, JRNL AUTH 3 C.GUIBOURDENCHE,S.HAENNI,S.HOLZINGER,J.HUNZIKER,A.IZAAC, JRNL AUTH 4 M.KAUFMANN,L.LEDER,H.J.MARTUS,P.VON MATT,V.POLYAKOV, JRNL AUTH 5 P.ROETHLISBERGER,G.ROMA,N.STIEFL,M.UTENG,A.LERCHNER JRNL TITL X-RAY STRUCTURES AND FEASIBILITY ASSESSMENT OF CLK2 JRNL TITL 2 INHIBITORS FOR PHELAN-MCDERMID SYNDROME. JRNL REF CHEMMEDCHEM V. 13 1997 2018 JRNL REFN ESSN 1860-7187 JRNL PMID 29985556 JRNL DOI 10.1002/CMDC.201800344 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 10362 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 545 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2804 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 17 REMARK 3 SOLVENT ATOMS : 109 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : -0.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.328 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.230 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.880 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6FYI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009132. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10909 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 19.460 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.66600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3NR9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.1M HEPES, PH 7.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.72200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.92000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.26550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.92000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.72200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.26550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 129 REMARK 465 MET A 130 REMARK 465 ARG A 131 REMARK 465 SER A 132 REMARK 465 SER A 133 REMARK 465 SER A 134 REMARK 465 HIS A 135 REMARK 465 SER A 136 REMARK 465 SER A 137 REMARK 465 ARG A 138 REMARK 465 ARG A 139 REMARK 465 ALA A 140 REMARK 465 LYS A 141 REMARK 465 SER A 142 REMARK 465 VAL A 143 REMARK 465 GLU A 144 REMARK 465 ASP A 145 REMARK 465 ASP A 146 REMARK 465 ALA A 147 REMARK 465 ALA A 484 REMARK 465 GLU A 485 REMARK 465 PRO A 486 REMARK 465 PRO A 487 REMARK 465 ASN A 488 REMARK 465 LYS A 489 REMARK 465 LEU A 490 REMARK 465 TRP A 491 REMARK 465 ASP A 492 REMARK 465 SER A 493 REMARK 465 SER A 494 REMARK 465 ARG A 495 REMARK 465 ASP A 496 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 162 -43.25 -151.92 REMARK 500 LYS A 196 151.35 -49.88 REMARK 500 ASP A 219 76.80 -152.14 REMARK 500 LEU A 246 -166.90 -124.20 REMARK 500 THR A 289 -37.63 72.78 REMARK 500 ASP A 290 48.37 -109.95 REMARK 500 ASP A 327 90.13 54.90 REMARK 500 SER A 343 152.33 75.27 REMARK 500 SER A 359 -145.50 -148.36 REMARK 500 ARG A 481 37.67 -86.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAE A 501 DBREF 6FYI A 131 496 UNP P49760 CLK2_HUMAN 130 495 SEQADV 6FYI SER A 129 UNP P49760 EXPRESSION TAG SEQADV 6FYI MET A 130 UNP P49760 EXPRESSION TAG SEQRES 1 A 368 SER MET ARG SER SER SER HIS SER SER ARG ARG ALA LYS SEQRES 2 A 368 SER VAL GLU ASP ASP ALA GLU GLY HIS LEU ILE TYR HIS SEQRES 3 A 368 VAL GLY ASP TRP LEU GLN GLU ARG TYR GLU ILE VAL SER SEQRES 4 A 368 THR LEU GLY GLU GLY THR PHE GLY ARG VAL VAL GLN CYS SEQRES 5 A 368 VAL ASP HIS ARG ARG GLY GLY ALA ARG VAL ALA LEU LYS SEQRES 6 A 368 ILE ILE LYS ASN VAL GLU LYS TYR LYS GLU ALA ALA ARG SEQRES 7 A 368 LEU GLU ILE ASN VAL LEU GLU LYS ILE ASN GLU LYS ASP SEQRES 8 A 368 PRO ASP ASN LYS ASN LEU CYS VAL GLN MET PHE ASP TRP SEQRES 9 A 368 PHE ASP TYR HIS GLY HIS MET CYS ILE SER PHE GLU LEU SEQRES 10 A 368 LEU GLY LEU SER THR PHE ASP PHE LEU LYS ASP ASN ASN SEQRES 11 A 368 TYR LEU PRO TYR PRO ILE HIS GLN VAL ARG HIS MET ALA SEQRES 12 A 368 PHE GLN LEU CYS GLN ALA VAL LYS PHE LEU HIS ASP ASN SEQRES 13 A 368 LYS LEU THR HIS THR ASP LEU LYS PRO GLU ASN ILE LEU SEQRES 14 A 368 PHE VAL ASN SER ASP TYR GLU LEU THR TYR ASN LEU GLU SEQRES 15 A 368 LYS LYS ARG ASP GLU ARG SER VAL LYS SER THR ALA VAL SEQRES 16 A 368 ARG VAL VAL ASP PHE GLY SER ALA THR PHE ASP HIS GLU SEQRES 17 A 368 HIS HIS SER THR ILE VAL SER THR ARG HIS TYR ARG ALA SEQRES 18 A 368 PRO GLU VAL ILE LEU GLU LEU GLY TRP SER GLN PRO CYS SEQRES 19 A 368 ASP VAL TRP SER ILE GLY CYS ILE ILE PHE GLU TYR TYR SEQRES 20 A 368 VAL GLY PHE THR LEU PHE GLN THR HIS ASP ASN ARG GLU SEQRES 21 A 368 HIS LEU ALA MET MET GLU ARG ILE LEU GLY PRO ILE PRO SEQRES 22 A 368 SER ARG MET ILE ARG LYS THR ARG LYS GLN LYS TYR PHE SEQRES 23 A 368 TYR ARG GLY ARG LEU ASP TRP ASP GLU ASN THR SER ALA SEQRES 24 A 368 GLY ARG TYR VAL ARG GLU ASN CYS LYS PRO LEU ARG ARG SEQRES 25 A 368 TYR LEU THR SER GLU ALA GLU GLU HIS HIS GLN LEU PHE SEQRES 26 A 368 ASP LEU ILE GLU SER MET LEU GLU TYR GLU PRO ALA LYS SEQRES 27 A 368 ARG LEU THR LEU GLY GLU ALA LEU GLN HIS PRO PHE PHE SEQRES 28 A 368 ALA ARG LEU ARG ALA GLU PRO PRO ASN LYS LEU TRP ASP SEQRES 29 A 368 SER SER ARG ASP HET EAE A 501 17 HETNAM EAE (1~{Z})-1-(3-ETHYL-5-METHOXY-1,3-BENZOTHIAZOL-2- HETNAM 2 EAE YLIDENE)PROPAN-2-ONE FORMUL 2 EAE C13 H15 N O2 S FORMUL 3 HOH *109(H2 O) HELIX 1 AA1 VAL A 198 LYS A 218 1 21 HELIX 2 AA2 SER A 249 ASN A 257 1 9 HELIX 3 AA3 PRO A 263 ASN A 284 1 22 HELIX 4 AA4 LYS A 292 GLU A 294 5 3 HELIX 5 AA5 THR A 344 ARG A 348 5 5 HELIX 6 AA6 ALA A 349 LEU A 354 1 6 HELIX 7 AA7 GLN A 360 GLY A 377 1 18 HELIX 8 AA8 ASP A 385 GLY A 398 1 14 HELIX 9 AA9 PRO A 401 THR A 408 1 8 HELIX 10 AB1 LYS A 410 LYS A 412 5 3 HELIX 11 AB2 THR A 425 CYS A 435 1 11 HELIX 12 AB3 PRO A 437 LEU A 442 5 6 HELIX 13 AB4 ALA A 446 LEU A 460 1 15 HELIX 14 AB5 THR A 469 LEU A 474 1 6 HELIX 15 AB6 GLN A 475 ALA A 480 5 6 SHEET 1 AA1 6 TRP A 158 LEU A 159 0 SHEET 2 AA1 6 TYR A 163 GLU A 171 -1 O TYR A 163 N LEU A 159 SHEET 3 AA1 6 GLY A 175 ASP A 182 -1 O GLN A 179 N VAL A 166 SHEET 4 AA1 6 ARG A 189 ILE A 195 -1 O LEU A 192 N VAL A 178 SHEET 5 AA1 6 HIS A 238 GLU A 244 -1 O PHE A 243 N ALA A 191 SHEET 6 AA1 6 MET A 229 TYR A 235 -1 N ASP A 231 O SER A 242 SHEET 1 AA2 2 LEU A 286 THR A 287 0 SHEET 2 AA2 2 THR A 332 PHE A 333 -1 O THR A 332 N THR A 287 SHEET 1 AA3 2 ILE A 296 PHE A 298 0 SHEET 2 AA3 2 VAL A 323 VAL A 325 -1 O ARG A 324 N LEU A 297 SHEET 1 AA4 2 TYR A 303 ASN A 308 0 SHEET 2 AA4 2 ARG A 313 VAL A 318 -1 O GLU A 315 N THR A 306 SHEET 1 AA5 2 PHE A 414 TYR A 415 0 SHEET 2 AA5 2 ARG A 418 LEU A 419 -1 O ARG A 418 N TYR A 415 SITE 1 AC1 7 ALA A 191 LYS A 193 GLU A 244 LEU A 246 SITE 2 AC1 7 GLY A 247 LEU A 297 HOH A 626 CRYST1 39.444 76.531 111.840 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025352 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013067 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008941 0.00000